{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T16:48:34Z","timestamp":1784047714583,"version":"3.55.0"},"reference-count":159,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T00:00:00Z","timestamp":1543190400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accp1.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Clinical Pharma"],"published-print":{"date-parts":[[2019,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Tumor necrosis factor (TNF) inhibitors significantly improved the treatment options for patients with ankylosing spondylitis. Unfortunately, currently, there is no strategy for sustaining remission of the disease with TNF inhibitors; after discontinuation, a high percentage of patients experience flares in a short time. Therefore, up\u2010to\u2010date, long\u2010term use of TNF inhibitors in patients with ankylosing spondylitis remains necessary. For this reason, the issue of the long\u2010term safety of TNF inhibitors in patients with ankylosing spondylitis raises concerns. Although TNF inhibitors are well established in ankylosing spondylitis treatment, the majority of studies on TNF inhibitors\u2019 safety have been performed in patients with rheumatoid arthritis. Until recently, there were very few studies of TNF inhibitors\u2019 safety in ankylosing spondylitis. Meanwhile, TNF inhibitors appear to have different safety profiles in ankylosing spondylitis and rheumatoid arthritis. In this review, we describe available data on the occurrence of adverse events associated with TNF inhibitor treatment in ankylosing spondylitis, including serious adverse events, infections, serious infections, tuberculosis, opportunistic infections, hepatitis B reactivation, malignancies, laboratory test abnormalities, autoimmune diseases, paradoxical adverse events, and heart failure.<\/jats:p>","DOI":"10.1002\/jcph.1348","type":"journal-article","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T17:49:48Z","timestamp":1543254588000},"page":"445-462","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["The Safety Profile of Tumor Necrosis Factor Inhibitors in Ankylosing Spondylitis: Are TNF Inhibitors Safer Than We Thought?"],"prefix":"10.1002","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0055-6415","authenticated-orcid":false,"given":"Jakub","family":"Wro\u0144ski","sequence":"first","affiliation":[{"name":"Department of Rheumatology National Institute of Geriatrics, Rheumatology and Rehabilitation  Warsaw Poland"},{"name":"Department of Disaster Medicine Medical University of Warsaw  Warsaw Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Fiedor","sequence":"additional","affiliation":[{"name":"Department of General and Transplantation Surgery Medical University of Warsaw  Warsaw Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,11,26]]},"reference":[{"key":"e_1_2_13_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket387"},{"key":"e_1_2_13_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210770"},{"issue":"7","key":"e_1_2_13_4_1","first-page":"246","article-title":"Non\u2010steroidal anti\u2010inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non\u2010radiographic axial spondyloarthritis) (Review)","author":"Fpb K","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"e_1_2_13_5_1","article-title":"TNF\u2010alpha inhibitors for ankylosing spondylitis","volume":"4","author":"Maxwell LJ","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_13_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211544"},{"key":"e_1_2_13_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505066"},{"key":"e_1_2_13_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew033"},{"key":"e_1_2_13_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2014.10.001"},{"key":"e_1_2_13_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2017.11.005"},{"key":"e_1_2_13_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-015-2929-7"},{"key":"e_1_2_13_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23333"},{"issue":"6","key":"e_1_2_13_13_1","first-page":"958","article-title":"Anti\u2010TNF therapy of ankylosing spondylitis in clinical practice: results from the Czech national registry ATTRA","volume":"27","author":"Pavelka K","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_13_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar1941"},{"issue":"6","key":"e_1_2_13_15_1","first-page":"857","article-title":"Drug survival of the first course of anti\u2010TNF agents in patients with rheumatoid arthritis and seronegative spondyloarthritis: analysis from the monitornet database","volume":"31","author":"Scir\u00e8 CA","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_13_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2014.06.012"},{"key":"e_1_2_13_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000007145"},{"key":"e_1_2_13_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-013-2772-6"},{"key":"e_1_2_13_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-017-8623-6"},{"key":"e_1_2_13_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep32768"},{"key":"e_1_2_13_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.4187"},{"key":"e_1_2_13_22_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.19.2275"},{"key":"e_1_2_13_23_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.091107"},{"key":"e_1_2_13_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2016.02.028"},{"key":"e_1_2_13_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.098822"},{"key":"e_1_2_13_26_1","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2017.5003"},{"key":"e_1_2_13_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu255"},{"key":"e_1_2_13_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210715"},{"key":"e_1_2_13_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes305"},{"key":"e_1_2_13_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.10524"},{"key":"e_1_2_13_31_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2014.00048","article-title":"Classical and paradoxical effects of TNF\u2010\u03b1 on bone homeostasis","volume":"5","author":"Osta B","year":"2014","journal-title":"Front Immunol"},{"issue":"6","key":"e_1_2_13_32_1","first-page":"S34","article-title":"Immunological basis for the use of TNFalpha\u2010blocking agents in ankylosing spondylitis and immunological changes during treatment","volume":"20","author":"Zou JX","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_13_33_1","doi-asserted-by":"publisher","DOI":"10.2174\/187152809787582543"},{"key":"e_1_2_13_34_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-012567"},{"key":"e_1_2_13_35_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150057"},{"key":"e_1_2_13_36_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110373"},{"key":"e_1_2_13_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-013-2387-z"},{"key":"e_1_2_13_38_1","doi-asserted-by":"publisher","DOI":"10.1590\/0074-02760150235"},{"key":"e_1_2_13_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.12530"},{"key":"e_1_2_13_40_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150177"},{"key":"e_1_2_13_41_1","doi-asserted-by":"publisher","DOI":"10.1086\/505430"},{"key":"e_1_2_13_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jidsymp.5650031"},{"key":"e_1_2_13_43_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153816"},{"key":"e_1_2_13_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-016-3575-3"},{"key":"e_1_2_13_45_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2016.1240783"},{"key":"e_1_2_13_46_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203407"},{"key":"e_1_2_13_47_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key023"},{"key":"e_1_2_13_48_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.137422"},{"key":"e_1_2_13_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2013.07.009"},{"key":"e_1_2_13_50_1","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2017.1325034"},{"issue":"5","key":"e_1_2_13_51_1","first-page":"679","article-title":"Influence of TNF\u2010\u03b1 blockers on the oral prevalence of opportunistic microorganisms in ankylosing spondylitis patients","volume":"30","author":"Pereira DFA","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_13_52_1","doi-asserted-by":"publisher","DOI":"10.1038\/cti.2016.68"},{"key":"e_1_2_13_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23346"},{"key":"e_1_2_13_54_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-eular.3188"},{"key":"e_1_2_13_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2013.11.014"},{"key":"e_1_2_13_56_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20130"},{"key":"e_1_2_13_57_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar2868"},{"key":"e_1_2_13_58_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-013-2385-1"},{"key":"e_1_2_13_59_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.081324"},{"key":"e_1_2_13_60_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-012-1960-1"},{"key":"e_1_2_13_61_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.127233"},{"key":"e_1_2_13_62_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-011-1934-7"},{"key":"e_1_2_13_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80060-9"},{"key":"e_1_2_13_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.11.025"},{"key":"e_1_2_13_65_1","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2012.646986"},{"key":"e_1_2_13_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6101(01)00020-X"},{"key":"e_1_2_13_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2004.11.001"},{"key":"e_1_2_13_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.12171"},{"key":"e_1_2_13_69_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.149419"},{"key":"e_1_2_13_70_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2016.1238458"},{"key":"e_1_2_13_71_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.2046"},{"key":"e_1_2_13_72_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210708"},{"key":"e_1_2_13_73_1","doi-asserted-by":"publisher","DOI":"10.1001\/2012.jama.10857"},{"key":"e_1_2_13_74_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f1939"},{"key":"e_1_2_13_75_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.030528"},{"key":"e_1_2_13_76_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-011-1895-y"},{"key":"e_1_2_13_77_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2008.02029.x"},{"key":"e_1_2_13_78_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar2404"},{"key":"e_1_2_13_79_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes350"},{"key":"e_1_2_13_80_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23716"},{"key":"e_1_2_13_81_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew214"},{"key":"e_1_2_13_82_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2007.107"},{"key":"e_1_2_13_83_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21675"},{"key":"e_1_2_13_84_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24287"},{"key":"e_1_2_13_85_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38339"},{"key":"e_1_2_13_86_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2002.004721"},{"key":"e_1_2_13_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2010.08.005"},{"key":"e_1_2_13_88_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.37740"},{"key":"e_1_2_13_89_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209270"},{"key":"e_1_2_13_90_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20037"},{"key":"e_1_2_13_91_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2012.05189.x"},{"key":"e_1_2_13_92_1","doi-asserted-by":"publisher","DOI":"10.15226\/2475-4676\/2\/4\/00127"},{"key":"e_1_2_13_93_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.112136"},{"key":"e_1_2_13_94_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119897"},{"key":"e_1_2_13_95_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-012-2072-7"},{"key":"e_1_2_13_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.12.025"},{"key":"e_1_2_13_97_1","doi-asserted-by":"publisher","DOI":"10.1080\/03009742.2016.1209554"},{"issue":"3","key":"e_1_2_13_98_1","first-page":"401","article-title":"Anti\u2010nuclear antibodies, anti\u2010DNA and C4 complement evolution in rheumatoid arthritis and ankylosing spondylitis treated with TNF\u2010alpha blockers","volume":"26","author":"Gonnet\u2010Gracia C","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_13_99_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21190"},{"key":"e_1_2_13_100_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205318"},{"key":"e_1_2_13_101_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar1440"},{"issue":"2","key":"e_1_2_13_102_1","first-page":"121","article-title":"[Antinuclear, anti\u2010dsDNA and anti\u2010ENA antibodies in patients affected with rheumatoid arthritis or ankylosing spondylitis during treatment with infliximab]","volume":"58","author":"Hoxha A","year":"2006","journal-title":"Reumatismo"},{"key":"e_1_2_13_103_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2017.1372421"},{"key":"e_1_2_13_104_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2016-000314"},{"key":"e_1_2_13_105_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-013-2361-9"},{"issue":"10","key":"e_1_2_13_106_1","first-page":"1955","article-title":"Leukocytoclastic vasculitis associated with tumor necrosis factor\u2010\u03b1 blocking agents","volume":"31","author":"Mohan N","year":"2004","journal-title":"J Rheumatol"},{"key":"e_1_2_13_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2006.02.010"},{"key":"e_1_2_13_108_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket125"},{"key":"e_1_2_13_109_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-015-3134-4"},{"key":"e_1_2_13_110_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar4582"},{"key":"e_1_2_13_111_1","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/671935"},{"key":"e_1_2_13_112_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-013-2419-8"},{"key":"e_1_2_13_113_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-012-2625-8"},{"key":"e_1_2_13_114_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes375"},{"key":"e_1_2_13_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2010.06.004"},{"key":"e_1_2_13_116_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208490"},{"key":"e_1_2_13_117_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.53.3.457"},{"key":"e_1_2_13_118_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200109)44:9<1977::AID-ART345>3.0.CO;2-6"},{"key":"e_1_2_13_119_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203582"},{"key":"e_1_2_13_120_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-015-0489-2"},{"key":"e_1_2_13_121_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2011.05.005"},{"key":"e_1_2_13_122_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.103192"},{"key":"e_1_2_13_123_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.052092"},{"key":"e_1_2_13_124_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210931"},{"key":"e_1_2_13_125_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2014.969368"},{"key":"e_1_2_13_126_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.087288"},{"key":"e_1_2_13_127_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar1724"},{"key":"e_1_2_13_128_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.08.012"},{"key":"e_1_2_13_129_1","first-page":"700","article-title":"Anti\u2010tumour necrosis factor alpha therapy and increased risk of de novo psoriasis: is it really a paradoxical side effect?","volume":"30","author":"Joyau C","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_13_130_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2010.04.003"},{"key":"e_1_2_13_131_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09329.x"},{"key":"e_1_2_13_132_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2008.06.004"},{"key":"e_1_2_13_133_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(03)00382-2"},{"key":"e_1_2_13_134_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.6.561"},{"key":"e_1_2_13_135_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22669"},{"key":"e_1_2_13_136_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2011.10.001"},{"issue":"12","key":"e_1_2_13_137_1","first-page":"2273","article-title":"The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects","volume":"22","author":"Mielants H","year":"1995","journal-title":"J Rheumatol"},{"key":"e_1_2_13_138_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13246"},{"issue":"10","key":"e_1_2_13_139_1","first-page":"s2127","article-title":"Tumor necrosis factor inhibitors for sarcoidosis [abstract]","volume":"69","author":"Wade S","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"e_1_2_13_140_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.124.1.177"},{"key":"e_1_2_13_141_1","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2016.57.1.272"},{"key":"e_1_2_13_142_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-009-1349-x"},{"key":"e_1_2_13_143_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00393-016-0262-4"},{"key":"e_1_2_13_144_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000124490.27666.B2"},{"key":"e_1_2_13_145_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000077913.60364.D2"},{"key":"e_1_2_13_146_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2008.02.025"},{"key":"e_1_2_13_147_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202136"},{"key":"e_1_2_13_148_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23281"},{"key":"e_1_2_13_149_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-006-0215-3"},{"key":"e_1_2_13_150_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2003.09.039"},{"issue":"10","key":"e_1_2_13_151_1","first-page":"s840","article-title":"Incidence of congestive heart failure in subjects with rheumatoid arthritis receiving anti\u2010tumour necrosis factor drugs: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis [abstract]","volume":"66","author":"Sijl A","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"e_1_2_13_152_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.067660"},{"key":"e_1_2_13_153_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20371"},{"key":"e_1_2_13_154_1","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e3181d06f5b"},{"key":"e_1_2_13_155_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20333"},{"key":"e_1_2_13_156_1","article-title":"Cardiovascular events in ankylosing spondylitis: a 2018 meta\u2010analysis","author":"Mathieu S","journal-title":"Ann Rheum Dis"},{"key":"e_1_2_13_157_1","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2470"},{"key":"e_1_2_13_158_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.24492"},{"key":"e_1_2_13_159_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-010-1402-x"},{"key":"e_1_2_13_160_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2004.09.002"}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjcph.1348","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jcph.1348","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T18:51:30Z","timestamp":1694717490000},"score":1,"resource":{"primary":{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/10.1002\/jcph.1348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,26]]},"references-count":159,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["10.1002\/jcph.1348"],"URL":"https:\/\/doi.org\/10.1002\/jcph.1348","archive":["Portico"],"relation":{},"ISSN":["0091-2700","1552-4604"],"issn-type":[{"value":"0091-2700","type":"print"},{"value":"1552-4604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,26]]},"assertion":[{"value":"2018-08-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-27","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}